Table 2 Laboratory results and imaging of 83 autoimmune encephalitis (AE) cases with co-existence of multiple anti-neuronal antibodies
Variables | Positive number n(%) |
|---|---|
EEG (n = 48) | |
 Slow activity | 28(58.3%) |
 Epileptic activity | 12(25.0%) |
 Mild or no abnormal | 9(18.7%) |
Brain MRI (n = 66) | |
 Frontal lobe | 6(9.1%) |
 Temporal lobes | 18(27.2%) |
 Parietal lobe | 2(3.0%) |
 Occipital lobe | 4(6.0%) |
 Hippocampus | 23(34.8%) |
 Basal ganglia | 6(9.1%) |
 Brainstem | 4(6.1%) |
 No abnormalities | 33(50.0%) |
Antibodies of AE | |
 Anti-neuronal surface antigen antibodies | |
  GABABR | 37(44.6%) |
  NMDAR | 37(44.6%) |
  LGI1 | 17(20.5%) |
  CASPR2 | 12(14.5%) |
  AMPAR | 6(7.2%) |
  IgLON5 | 2(2.4%) |
  VGKC | 1(1.2%) |
  DPPX | 1(1.2%) |
 Anti-neuronal intracellular antigen antibodies | |
  Hu | 18(21.7%) |
  GAD65 | 8(9.6%) |
  SOX 1 | 8(9.6%) |
  Yo | 8(9.6%) |
  Ma2 | 6(7.2%) |
  CV2 | 4(4.8%) |
  Amphiphsin | 4(4.8%) |
  Ri | 2(2.4%) |
  Tr | 1(1.2%) |
  Titin | 1(1.2%) |